09:15 AM EDT, 07/22/2024 (MT Newswires) -- Health care stocks were advancing premarket Monday with the Health Care Select Sector SPDR Fund ( XLV ) 0.3% higher and the iShares Biotechnology ETF ( IBB ) up 0.5% recently.

IQVIA Holdings ( IQV ) was up over 6% after it reported higher Q2 adjusted earnings and revenue. The company also raised its 2024 adjusted EPS forecast.

Zymeworks ( ZYME ) advanced by over 5% after saying the Food and Drug Administration has cleared the investigational new drug application for its experimental cancer therapy, ZW191.

Johnson & Johnson ( JNJ ) said it has filed a supplemental new drug application with the US Food and Drug Administration for its Spravato CIII nasal spray as a monotherapy for adults with treatment-resistant depression. Johnson & Johnson ( JNJ ) was 0.1% lower pre-bell.